Cargando…
Growth hormone treatment in Prader-Willi syndrome patients: systematic review and meta-analysis
BACKGROUND: Growth hormone (GH) treatment is currently recommended in Prader-Willi syndrome (PWS) patients. OBJECTIVES: To evaluate the impact (efficacy and safety) of the use of recombinant human GH (rhGH) as a treatment for PWS. METHOD: We performed a systematic review and, where possible, meta-an...
Autores principales: | Passone, Caroline de Gouveia Buff, Franco, Ruth Rocha, Ito, Simone Sakura, Trindade, Evelinda, Polak, Michel, Damiani, Durval, Bernardo, Wanderley Marques |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7213882/ https://www.ncbi.nlm.nih.gov/pubmed/32411831 http://dx.doi.org/10.1136/bmjpo-2019-000630 |
Ejemplares similares
-
PRADER-WILLI SYNDROME: WHAT IS THE GENERAL PEDIATRICIAN SUPPOSED TO
DO? - A REVIEW
por: Passone, Caroline Buff Gouveia, et al.
Publicado: (2018) -
Growth Hormone Treatment for Adults With Prader-Willi Syndrome: A Meta-Analysis
por: Rosenberg, Anna G W, et al.
Publicado: (2021) -
Adrenal insufficiency in patients with Prader-Willi syndrome
por: Kusz, Marcin Jerzy, et al.
Publicado: (2022) -
Prader-Willi syndrome: endocrine manifestations and management
por: Alves, Crésio, et al.
Publicado: (2020) -
Genotype-Phenotype Relationships and Endocrine Findings in Prader-Willi Syndrome
por: Costa, Régis Afonso, et al.
Publicado: (2019)